Alcohol Use Disorder and Hepatitis C Prevention and Care in People Who Inject Drugs: The State of Play

Archive ouverte

Marcellin, Fabienne | Jaquet, Antoine | Lazarus, Jeffrey, V | Molina, Patricia | Carrieri, Patrizia, M.

Edité par CCSD ; Thieme Publishing -

International audience. Safe and effective treatment with direct-acting antivirals (DAAs) has ushered in an era in which hepatitis C virus (HCV) elimination, as set out by the World Health Organization, is possible. However, alcohol use disorder (AUD) has the potential to reduce the benefits of prevention interventions and reduce access to and continuity of HCV care in at-risk populations, such as people who inject drugs (PWID). We review the literature on the consequences of AUD on the effectiveness of HCV prevention and the cascade of care in PWID and provide recommendations for future research in the field of alcohol use and HCV.

Suggestions

Du même auteur

Patient-reported outcomes to enhance person-centred HIV care

Archive ouverte | Kall, Meaghan | CCSD

International audience. Quality of life has been proposed as the fourth 90 to complement the UNAIDS 90-90-90 targets to monitor the global HIV response, highlighting a need to address the holistic needs of people li...

European ‘NAFLD Preparedness Index’ — Is Europe ready to meet the challenge of fatty liver disease?

Archive ouverte | Lazarus, Jeffrey, V | CCSD

International audience. Background & aims: Non-alcoholic fatty liver disease (NAFLD), which is closely associated with obesity, metabolic syndrome, and diabetes, is a highly prevalent emerging condition that can be ...

Author response: Improving patient‐provider communication by reducing stigma associated with liver disease

Archive ouverte | Carrieri, Patrizia | CCSD

International audience. No abstract available

Chargement des enrichissements...